P2-receptor-mediated inhibition of serotonin release in the rat brain cortex
Abstract
The possibility of a P2-receptor-mediated modulation of the release of serotonin in the rat brain cortex was investigated in occipito-parietal slices preincubated with [3H]serotonin and then superfused and stimulated electrically (10 pulses, 1 Hz). Adenosine receptor agonists decreased the stimulation-evoked overflow of tritium at best slightly; the selective A1 agonist N6-cyclopentyl-adenosine caused no change. Several nucleotides had more marked effects: ATP (3-1000 microM), adenosine-5'-O-(3-thiotriphosphate) (3-300 microM) and P1,P5-di(adenosine-5')-pentaphosphate (3-300 microM) decreased the evoked overflow by up to ca 35%. AMP, alpha,beta-methylene-ATP and UTP produced smaller decreases and 2-methylthio-ATP and UMP caused no change. The inhibition by ATP was attenuated both by the P1-receptor antagonist 8-(p-sulphophenyl)-theophylline (100 microM) and by the P2-receptor antagonist suramin (300 microM) but was not changed by indomethacin (10 microM) and NG-nitro-L-arginine (10 microM). We conclude that the release of serotonin in the rat brain cortex is inhibited through presynaptic P1-receptors (which are not A1) as well as P2-receptors. Inhibition of release via P2-receptors has been previously shown for noradrenaline (brain cortex and hippocampus) and dopamine (neostriatum) and, hence, may be widespread. Differences between transmitter systems exist, however, in the degree of their sensitivity to presynaptic P2-receptor-mediated modulation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of presynaptic P2R in rat cortical slices inhibits electrically stimulated 5-HT release.
“Although there is scarce evidence regarding the localization of P2X7R in monoaminergic terminals, studies conducted with radiolabeled ligands indicate that activation of presynaptic P2R in rat cortical slices inhibits electrically-stimulated 5-HT release [94].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [94]
Cites
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585 · see citing works
Lewis, C. J., Neidhart, S., Holy, C., North, R. A., Buell, G. N., & Surprenant, A. (1995) · Nature · doi:10.1038/377432a0 · Cited by 997 · see citing works
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 659 · see citing works
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis, M. F., Schulz, R., Hutchison, A. J., Do, U. H., Sills, M. A., & Williams, M. J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21094-1 · Cited by 546 · see citing works
Drug‐Induced Changes in the Release of3H‐Monoamines from Field Stimulated Rat Brain Slices
Farnebo, L., & Hamberger, B. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1971.tb05213.x · Cited by 454 · see citing works
The mechanism of neuronal and extraneuronal transport of catecholamines
Starke, K. (1976) · Neuroscience · doi:10.1016/0306-4522(76)90140-8 · Cited by 280 · see citing works
Self-citationLanger, S. Z. (1978) · Nature · doi:10.1038/275479b0 · Cited by 243 · see citing works
Kinetic characteristics of nitric oxide synthase from rat brain
Knowles, R. G., Palacios‐Callender, M., Palmer, R. M. J., & Moncada, S. (1990) · Biochemical Journal · doi:10.1042/bj2690207 · Cited by 202 · see citing works
Purinoceptors in the Nervous System*
Fredholm, B. B. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00135.x · Cited by 173 · see citing works
Harms, H. H., Wardeh, G., & Mulder, A. H. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90107-3 · Cited by 153 · see citing works
Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery
Shinozuka, K., Bjur, R. A., & Westfall, D. P. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173391 · Cited by 124 · see citing works
von Kügelgen, I., Häussinger, D., & Starker, K. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169313 · Cited by 107 · see citing works
Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves
FUDER, H., & Muscholl, E. (2006) · Springer eBooks · doi:10.1007/bfb0049778 · Cited by 104 · see citing works
Crack, B. E., Beukers, M. W., McKechnie, K. C. W., IJzerman, A. P., & Leff, P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17157.x · Cited by 98 · see citing works
A1 and A2 adenosine receptors modulate acetylcholine release from brain slices
Spignoli, G., Pedata, F., & Pepeu, G. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90475-8 · Cited by 96 · see citing works
Williams, M. J., Braunwalder, A. F., & Erickson, T. J. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511410 · Cited by 95 · see citing works
von Kügelgen, I., Schöffel, E., & Starke, K. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00260607 · Cited by 92 · see citing works
Self-citationEvidence for P2‐purinoceptor‐mediated inhibition of noradrenaline release in rat brain cortex
von Kügelgen, I., Späth, L., & Starke, K. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17066.x · Cited by 82 · see citing works
Self-citationExcitatory effects of adenosine 5′-triphosphate on rat locus coeruleus neurones
Tschöpl, M., Harms, L., Nörenberg, W., & Illés, P. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90234-u · Cited by 79 · see citing works
The Mechanism of neuronal and extraneuronal transport of catecholamines
Paton, D. M. (1976) · Medical Entomology and Zoology · Cited by 69 · see citing works
Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release
von Kügelgen, I., Kurz, K., & Starke, K. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90330-i · Cited by 68 · see citing works
Self-citationBradykinin and postganglionic sympathetic transmission
Starke, K., Peskar, B. A., Schumacher, K., & Taube, H. D. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508633 · Cited by 62 · see citing works
Self-citationGonçalves, J., & Queiróz, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15168.x · Cited by 59 · see citing works
Kurz, K., von Kügelgen, I., & Starke, K. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13986.x · Cited by 57 · see citing works
Self-citationB�ltmann, R., Wittenburg, H., Pause, B., Kurz, G., Nickel, P., & Starke, K. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168442 · Cited by 57 · see citing works
Self-citationFUDER, H., & Muth, U. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171333 · Cited by 52 · see citing works
Trendelenburg, A., Trendelenburg, M., Starke, K., & Limberger, N. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178202 · Cited by 52 · see citing works
Self-citationP2‐purinoceptor‐mediated inhibition of noradrenaline release in rat atria
von Kügelgen, I., Stoffel, D., & Starke, K. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15870.x · Cited by 50 · see citing works
Self-citationP2-Receptor-mediated inhibition of noradrenaline release in the rat hippocampus
Koch, H., von Kügelgen, I., & Starke, K. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005003 · Cited by 48 · see citing works
Self-citationConnolly, G. P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb17199.x · Cited by 47 · see citing works
B�ltmann, R., Driessen, B., Gon�alves, J., & Starke, K. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171048 · Cited by 33 · see citing works
Self-citationGrimm, U., FUDER, H., Moser, U., B�umert, H., Mutschler, E., & Lambrecht, G. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178199 · Cited by 31 · see citing works
Broad, R. M., & Fredholm, B. B. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12807-3 · Cited by 25 · see citing works
Feuerstein, T. J., B�r, K. I., & L�cking, C. H. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165632 · Cited by 24 · see citing works
Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery
Fujioka, M., & Cheung, D. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90246-9 · Cited by 22 · see citing works
Flagged first, then by citations
3 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Purine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352 · see citing works
Adenosine and ATP Receptors in the Brain
Burnstock, G., Fredholm, B. B., & Verkhratsky, A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347627 · Cited by 188 · see citing works
Braun, N., Sévigny, J., Robson, S. C., Enjyoji, K., Guckelberger, O., Hammer, K., Virgilio, F. D., & Zimmermann, H. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01342.x · Cited by 169 · see citing works
Molecular physiology of P2 receptors in the central nervous system
Illés, P., & Ribeiro, J. A. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.030 · Cited by 155 · see citing works
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129 · see citing works
Guzman, S. J., & Gerevich, Z. (2016) · Neural Plasticity · doi:10.1155/2016/1207393 · Cited by 89 · see citing works
P2 Receptor Signaling in Neurons and Glial Cells of the Central Nervous System
Köles, L., Leichsenring, A., Rubini, P., & Illés, P. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00014-x · Cited by 71 · see citing works
Functions of neuronal P2Y receptors
Hussl, S., & Boehm, S. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0063-8 · Cited by 68 · see citing works
Luthardt, J. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00069-4 · Cited by 66 · see citing works
P2 receptor-mediated modulation of neurotransmitter release—an update
Sperlágh, B., Heinrich, A., & Csölle, C. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9080-0 · Cited by 56 · see citing works
Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex
Wirkner, K., Köles, L., Thümmler, S., Luthardt, J., Poelchen, W., Franke, H., Fürst, S., & Illés, P. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00199-x · Cited by 43 · see citing works
Kukulski, F., Sévigny, J., & Komoszyński, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.044 · Cited by 38 · see citing works
Werthwein, S., Bauer, U. S., Nakazi, M., Kathmann, M., & Schlicker, E. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702534 · Cited by 37 · see citing works
P2 receptor-mediated inhibition of dopamine release in rat neostriatum
Trendelenburg, A., & Bültmann, R. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00577-1 · Cited by 35 · see citing works
ATP-mediated signalling in the central synapses
Lalo, U., & Pankratov, Y. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109477 · Cited by 33 · see citing works
ATP Receptors for the Protection of Hippocampal Functions
Inoue, K. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.405 · Cited by 30 · see citing works
Chapter 16 The functions of ATP receptors in the synaptic transmission in the hippocampus
Inoue, K., Koizumi, S., Ueno, S., Kita, A., & Tsuda, M. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63556-6 · Cited by 29 · see citing works
P2 receptors are involved in the mediation of motivation-related behavior
Krügel, U., Spies, O., Regenthal, R., Illés, P., & Kittner, H. (2004) · Purinergic Signalling · doi:10.1007/s11302-004-4745-4 · Cited by 29 · see citing works
Bjelobaba, I. M., Stojiljković, M., Peković, S., Đačić, S., Lavrnja, I. C., Savić, D. Z., Rakić, L., & Nedeljković, N. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9159-8 · Cited by 28 · see citing works
Monoamine involvement in the antidepressant-like effect induced by P2 blockade
Diniz, C. R. A. F., Rodrigues, M., Casarotto, P. C., Pereira, V. S., Crestani, C. C., & Joca, S. R. L. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.011 · Cited by 25 · see citing works
Sebastião, A. M., Cunha, R. A., Cascalheira, J. F., & Ribeiro, J. A. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63555-4 · Cited by 25 · see citing works
Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline
Pedrazza, E. L., Rico, E. P., Senger, M. R., Pedrazza, L., Zimmermann, F. F., Sarkis, J. J. F., Bogo, M. R., & Bonan, C. D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.013 · Cited by 22 · see citing works
Presynaptic Adenosine and P2Y Receptors
Gonçalves, J., & Queiróz, G. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_11 · Cited by 22 · see citing works
von Kügelgen, I., Nörenberg, W., Koch, H., Meyer, A., Illéš, P., & Starke, K. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)63554-2 · Cited by 21 · see citing works
Self-citationP2Y1 Receptors – Properties and Functional Activities
Barańska, J., Czajkowski, R., & Pomorski, P. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_57 · Cited by 20 · see citing works
Fukui, M., Nakagawa, T., Minami, M., & Satoh, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00947-5 · Cited by 14 · see citing works
Role of Purines and Pyrimidines in the Central Nervous System
Masino, S. A., & Dunwiddie, T. V. (2001) · Springer eBooks · doi:10.1007/978-3-662-09604-8_9 · Cited by 13 · see citing works
ATP-Mediated Signaling in the Nervous System
Sperlágh, B. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_10 · Cited by 9 · see citing works
Effects of pentobarbital on purinergic P2X receptors of rat dorsal root ganglion neurons
Kitahara, S., Yamashita, M., & Ikemoto, Y. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-111 · Cited by 9 · see citing works
Driessen, B., Bültmann, R., Jurna, I., & Baldauf, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00369-2 · Cited by 9 · see citing works
Serotonin modulates glutamatergic transmission in the rat olfactory tubercle
Hadley, J. K., & Halliwell, J. V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07084.x · Cited by 8 · see citing works
Purinergic Signalling in the Central Nervous System
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_8 · Cited by 6 · see citing works
Major depressive disorder (mdd): emerging immune targets at preclinical level
Varma, M., Kaur, A., Bhandari, R., Kumar, A., & Kuhad, A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2225216 · Cited by 5 · see citing works
Mechanism of the inhibitory action of ATP in rat hippocampus
Inoue, K., & Koizumi, S. (2001) · Drug Development Research · doi:10.1002/ddr.1103 · Cited by 4 · see citing works
Coppi, E. (2009) · Premio Tesi dottorato/Premio Tesi di dottorato · doi:10.36253/978-88-8453-905-2 · Cited by 2 · see citing works
Diniz, C. R. A. F., Rodrigues, M. W., Casarotto, P. C., Pereira, V. S., Crestani, C. C., & Joca, S. R. L. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/086983 · Cited by 2 · see citing works
Purinergic Signaling in Depression
Ribeiro, D. E., Kaster, M. P., Ulrich, H., Lisboa, S. F. D. S., & Joca, S. R. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-26945-5_7
Les mécanismes antiépileptiques de l’AppCH2ppA dans la sclérose tubéreuse de Bourneville
Pons-Bennaceur, A. (2018) · theses.fr (ABES) · doi:10.70675/bc0fd846z6521z4538zb18cz82c70f31c458
BindingDB Entry 50037061: Purine and pyrimidine (P2) receptors as drug targets.
BindingDB (2012) · UC San Diego · doi:10.7270/q2vx0h71
- Authors
- Von Kügelgen, I., Koch, H., & Starke, K.
- Affiliations
- University of Freiburg (DE)
- Corresponding author
- Starke, Klaus
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 1997-09
- Volume
- 36
- Issue
- 9
- Pages
- 1221-1227
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2086787066
- Cited by
- 38
- References
- 38
- Citations by year
- 2023: 3 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2012: 1
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Keywords
- purinergic receptors, serotonin release, presynaptic inhibition, cerebral cortex, ATP, adenosine receptors, suramin, adenosine receptor agonists, N6-cyclopentyladenosine
- MeSH terms
- Adenosine, Adenosine Triphosphate, Animals, Cerebral Cortex, Desipramine, Male, Methiothepin, Quipazine, Serotonin, Serotonin Antagonists, Dinucleoside Phosphates, 2-Chloroadenosine, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Receptors, Purinergic P2, Adenosine-5'-(N-ethylcarboxamide), Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review